These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 27017166)

  • 21. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.
    Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    J Hepatobiliary Pancreat Sci; 2016 Oct; 23(10):636-642. PubMed ID: 27474781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of postoperative nadir hemoglobin and blood transfusion on outcomes after operations for atherosclerotic vascular disease.
    Kougias P; Orcutt S; Pak T; Pisimisis G; Barshes NR; Lin PH; Bechara CF
    J Vasc Surg; 2013 May; 57(5):1331-7; discussion. PubMed ID: 23384496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium.
    Lopez-Aguiar AG; Ethun CG; Pawlik TM; Tran T; Poultsides GA; Isom CA; Idrees K; Krasnick BA; Fields RC; Salem A; Weber SM; Martin RCG; Scoggins CR; Shen P; Mogal HD; Beal EW; Schmidt C; Shenoy R; Hatzaras I; Maithel SK
    Ann Surg Oncol; 2019 Jun; 26(6):1814-1823. PubMed ID: 30877497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgery for perihilar cholangiocarcinoma from a viewpoint of age: Is it beneficial to octogenarians in an aging society?
    Akashi K; Ebata T; Mizuno T; Yokoyama Y; Igami T; Yamaguchi J; Onoe S; Nagino M
    Surgery; 2018 Nov; 164(5):1023-1029. PubMed ID: 30082134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of perioperative transfusion with 30-day morbidity and mortality in patients undergoing major vascular surgery.
    Obi AT; Park YJ; Bove P; Cuff R; Kazmers A; Gurm HS; Grossman PM; Henke PK
    J Vasc Surg; 2015 Apr; 61(4):1000-9.e1. PubMed ID: 25596978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical treatment of perihilar cholangiocarcinoma: early results of en bloc portal vein resection.
    Molina V; Sampson J; Ferrer J; Díaz A; Ayuso JR; Sánchez-Cabús S; Fuster J; García-Valdecasas JC
    Langenbecks Arch Surg; 2017 Feb; 402(1):95-104. PubMed ID: 28012034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of perioperative red blood cell transfusions in patients undergoing liver resection: a systematic review.
    Bennett S; Baker LK; Martel G; Shorr R; Pawlik TM; Tinmouth A; McIsaac DI; Hébert PC; Karanicolas PJ; McIntyre L; Turgeon AF; Barkun J; Fergusson D
    HPB (Oxford); 2017 Apr; 19(4):321-330. PubMed ID: 28161216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium.
    Zhang XF; Beal EW; Chakedis J; Chen Q; Lv Y; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Buettner S; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
    World J Surg; 2018 Sep; 42(9):2919-2929. PubMed ID: 29404753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practice to minimize the use of blood products improve outcome after hepatic resection for hepatocellular carcinoma.
    Shiba H; Ishida Y; Fujiwara Y; Wakiyama S; Gocho T; Ito R; Sakamoto T; Tsutsui N; lida T; Matsumoto M; Furukawa K; Haruki K; Hirohara S; Misawa T; Yanaga K
    Hepatogastroenterology; 2013 Oct; 60(127):1681-3. PubMed ID: 24634937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Major hepatectomies for perihilar cholangiocarcinoma: Predictors for clinically relevant postoperative complications using the International Study Group of Liver Surgery definitions.
    Dumitrascu T; Brasoveanu V; Stroescu C; Ionescu M; Popescu I
    Asian J Surg; 2016 Apr; 39(2):81-9. PubMed ID: 26103932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome.
    Nagino M; Kamiya J; Arai T; Nishio H; Ebata T; Nimura Y
    Surgery; 2005 Feb; 137(2):148-55. PubMed ID: 15674194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes following resection of intrahepatic cholangiocarcinoma.
    Tabrizian P; Jibara G; Hechtman JF; Franssen B; Labow DM; Schwartz ME; Thung SN; Sarpel U
    HPB (Oxford); 2015 Apr; 17(4):344-51. PubMed ID: 25395176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium.
    Schimizzi GV; Jin LX; Davidson JT; Krasnick BA; Ethun CG; Pawlik TM; Poultsides G; Tran T; Idrees K; Isom CA; Weber SM; Salem A; Hawkins WG; Strasberg SM; Doyle MB; Chapman WC; Martin RCG; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Maithel SK; Fields RC
    HPB (Oxford); 2018 Apr; 20(4):332-339. PubMed ID: 29169904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conditional probability of long-term survival after resection of hilar cholangiocarcinoma.
    Buettner S; Margonis GA; Kim Y; Gani F; Ethun CG; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins CR; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Maithel SK; Pawlik TM
    HPB (Oxford); 2016 Jun; 18(6):510-7. PubMed ID: 27317955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship of blood transfusion with peri-operative and long-term outcomes after major hepatectomy for metastatic colorectal cancer: a multi-institutional study of 456 patients.
    Postlewait LM; Squires MH; Kooby DA; Weber SM; Scoggins CR; Cardona K; Cho CS; Martin RCG; Winslow ER; Maithel SK
    HPB (Oxford); 2016 Feb; 18(2):192-199. PubMed ID: 26902139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical Outcomes for Perihilar Cholangiocarcinoma with Vascular Invasion.
    Higuchi R; Yazawa T; Uemura S; Izumo W; Ota T; Kiyohara K; Furukawa T; Egawa H; Yamamoto M
    J Gastrointest Surg; 2019 Jul; 23(7):1443-1453. PubMed ID: 30203230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perioperative blood transfusions do not impact overall and disease-free survival after curative rectal cancer resection: a propensity score analysis.
    Warschkow R; Güller U; Köberle D; Müller SA; Steffen T; Thurnheer M; Schmied BM; Tarantino I
    Ann Surg; 2014 Jan; 259(1):131-8. PubMed ID: 23470578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. External Validation of the Estimation of Physiologic Ability and Surgical Stress (E-PASS) Risk Model to Predict Operative Risk in Perihilar Cholangiocarcinoma.
    Coelen RJ; Olthof PB; van Dieren S; Besselink MG; Busch OR; van Gulik TM
    JAMA Surg; 2016 Dec; 151(12):1132-1138. PubMed ID: 27579510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.